Bausch Health Cos. Inc. BHC, +2.65% said Monday it has filed confidentially for the initial public offerings of its eye health business Bausch & Lomb, and its medical aesthetics business Global Solta. The company has not yet set terms for either deal, but expects them to completed on previously communicated timelines of the fourth quarter of 2021 or first half of 2022, based on market conditions. Shares were up 1.2% premarket and have gained 37% in the year to date, while the S&P 500 SPX, +0.31% has gained 18.7%.
View Article Origin Here